Developments and Efficiency Gains in Clone Selection and Upstream Process Development

To continue to accelerate development, the biopharmaceutical industry needs to improve clone selection and process development (PD). By partnering together, Sartorius and Waters are enabling process engineers to maximize yield, manufacturing efficiency, and drug-product quality — all while reducing development timelines

To learn more about the partnership from Sartorius and Waters and how we can support you, please check out the linked article!